热门资讯> 正文
Calliditas Therapeutics将从斯德哥尔摩纳斯达克退市
2024-09-16 22:45
- Calliditas Therapeutics AB (NASDAQ:CALT) said on Monday that Nasdaq Stockholm has decided the company will be delisted from Nasdaq Stockholm.
- The last day of trading in the share will be on Thursday, October 10, 2024.
More on Calliditas Therapeutics
- Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript
- Calliditas's Kinpegyo gets EU approval, setanaxib study meets endpoint
- Seeking Alpha’s Quant Rating on Calliditas Therapeutics
- Historical earnings data for Calliditas Therapeutics
- Financial information for Calliditas Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。